Pathologic complete responses after chemotherapy plus figitumumab in stage IV non-small-cell lung cancer

J Clin Oncol. 2011 Mar 1;29(7):e163-5. doi: 10.1200/JCO.2010.31.4641. Epub 2010 Dec 13.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Biopsy, Needle
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / etiology
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Carcinoma, Non-Small-Cell Lung / surgery
  • Chemotherapy, Adjuvant
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulins, Intravenous
  • Immunohistochemistry
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / etiology
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / surgery
  • Middle Aged
  • Neoplasm Staging
  • Pneumonectomy / methods
  • Positron-Emission Tomography
  • Remission Induction / methods
  • Smoking / adverse effects
  • Tomography, X-Ray Computed

Substances

  • Antibodies, Monoclonal
  • Immunoglobulins, Intravenous
  • figitumumab